Ex Parte Khare - Page 4

                Appeal 2006-2130                                                                                 
                Application 10/236,111                                                                           

                       Appellant argues that the most preferred range of monounsaturated                         
                fatty acids (MUFAs) disclosed by Schul has an upper limit of 75 percent                          
                MUFAs, which would represent a value of oleic acid content outside the                           
                claimed range.  Such argument is unpersuasive in that Schul’s teachings are                      
                not limited to the most preferred range described therein.  Concerning this                      
                matter, it is well settled that a reference must be considered in its entirety,                  
                and it is well-established that the disclosure of a reference is not limited to                  
                preferred embodiments or specific working examples contained therein.  See                       
                In re Fracalossi, 681 F.2d 792, 794 n.1, 215 USPQ 569, 570 n.1 (CCPA                             
                1982); In re Lamberti, 545 F.2d 747, 750, 192 USPQ 278, 280 (CCPA                                
                1976).  In this regard, we are bound to consider the disclosure of each                          
                reference for what it fairly teaches one of ordinary skill in the art, including                 
                not only the specific teachings, but also the inferences which one of ordinary                   
                skill in the art would reasonably have been expected to draw therefrom.  See                     
                In re Boe, 355 F.2d 961, 965, 148 USPQ 507, 510 (CCPA 1966); and In re                           
                Preda, 401 F.2d 825, 826, 159 USPQ 342, 344 (CCPA 1968).                                         
                       In the case before us, there is ample direction in the applied prior art                  
                for reasons set forth above and in the Answer that would have suggested the                      
                use of an ester moiety with an oleic acid content within the claimed range in                    
                formulating the sterol ester composition of Schul.  In this regard, the mere                     
                fact that Schul may suggest sterol ester compositions having an oleic acid                       
                content outside of the here claimed oleic acid content range does not detract                    
                from Schul’s teachings using sterol ester compositions that include oleic                        
                acid moiety contents within the here claimed range.  Indeed, Schul (para.                        
                0017) notes expected health benefits are associated with high levels of                          
                MUFAs.  While solubility of the sterol compositions is a concern noted by                        

                                                       4                                                         


Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007